Firestone Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3,903
Closed -$200K – 147
2023
Q4
$200K Buy
3,903
+6
+0.2% +$315 0.06% 129
2023
Q3
$226K Buy
3,897
+500
+15% +$30.6K 0.08% 115
2023
Q2
$210K Hold
3,397
– – 0.07% 126
2023
Q1
$235K Buy
3,397
+350
+11% +$24.7K 0.08% 106
2022
Q4
$219K Sell
3,047
-10
-0.3% -$754 0.08% 108
2022
Q3
$217K Hold
3,057
– – 0.09% 103
2022
Q2
$235K Hold
3,057
– – 0.09% 99
2022
Q1
$223K Buy
+3,057
New +$205K 0.07% 114
2021
Q4
– Sell
-3,057
Closed -$204K – 165
2021
Q3
$204K Hold
3,057
– – 0.07% 115
2021
Q2
$204K Hold
3,057
– – 0.07% 112
2021
Q1
$193K Buy
3,057
+10
+0.3% +$622 0.07% 111
2020
Q4
$189K Hold
3,047
– – 0.07% 108
2020
Q3
$184K Hold
3,047
– – 0.08% 92
2020
Q2
$179K Hold
3,047
– – 0.08% 91
2020
Q1
$170K Hold
3,047
– – 0.09% 88
2019
Q4
$196K Buy
+3,047
New +$175K 0.08% 95

Other funds holding BMY

Firestone Capital Management's BMY Position: Q1 2024 in Review

Firestone Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 3,903 shares — an estimated $200K sold.

Firestone Capital Management first reported a position in BMY in Q4 2019 and held it in 16 quarters. The position peaked at $235K in Q1 2023. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Firestone Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Firestone Capital Management sold 3,903 Bristol-Myers Squibb shares in Q1 2024, an estimated $200K.
  • Firestone Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 16 quarters.
  • Firestone Capital Management's Bristol-Myers Squibb position peaked at $235K in Q1 2023.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Firestone Capital Management's 13F filing for Q1 2024, filed 7 May 2024.